logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-112. Frequency of use of primary drug of clients entering inpatient treatment, 2011 or most recent year available

Part (i) New opioid inpatient clients by country and frequency of use (%)

CountryNot used in the past month/ OccasionalOnce a week or less2 - 6 times per weekDailyFrequency known (n)Frequency unknown
Belgium31.25.214.349.4772
Bulgaria9.02.66.482.1781
Czech Republic22.94.821.051.41055
Denmark::::01
Germany::::::
Estonia::::::
Ireland143.44.111.441.121924
Greece10.58.917.862.73703
Spain::::::
France14.3:28.657.170
Italy::::::
Cyprus12.525.0:62.580
Latvia::::::
Lithuania::::::
Luxembourg::::::
Hungary::33.366.760
Malta::::::
Netherlands14.35.72.977.13519
Austria56.23.130.010.813023
Poland2::::::
Portugal::::::
Romania:3.83.892.3263
Slovenia::::::
Slovakia2.6:20.576.9393
Finland9.4:40.650.0320
Sweden112.94.322.360.41395
United Kingdom3::::::
Croatia:::::20
Turkey1.42.23.692.86938
Norway
Total15.34.212.867.71964117
 

Notes:

: Indicates data are not available

Percentages are of clients whose frequency of use is known (n)

(1) Data are from 2010.

(2) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(3) Data are from 1st of April 2010 to 31st March 2011.

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Inpatient Treatment Centres

Page last updated: Friday, 26 April 2013